News | September 02, 2023
USFDA delegation visits Amneal Pharmaceutical facility in Matoda
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
The medical device sector is considered as one of the sunrise sectors in the country
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
SEZABY is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection
India's G20 Presidency will focus on three main priorities: Health Emergencies Prevention, Preparedness and Response (One Health & AMR); Access and Availability to Affordable Medical Countermeasures (Vaccines, Therapeutics, and Diagnostics); and Digital Health
Subscribe To Our Newsletter & Stay Updated
